Stockreport

ACADIA Pharmaceuticals Inc (ACAD) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF DAYBUE Sales (Q4 2024): $96.7 million, up 11% year over year and 6% sequentially. DAYBUE Sales (Full Year 2024): $348.4 million, up 97% from 2023. NUPLAZID Sales (Q [Read more]